Biocon
₹371
- Market Cap
- ₹56,843Cr.
- P/E Ratio
- 78.2
- P/B Ratio
- 1.77
- EPS (TTM)
- ₹4.74
- Div Yield
- 0.13%
- ROCE
- 3.61%
- ROE
- 1.4%
52W Low: ₹33852W High: ₹447
At a glance
- Sales have grown 15.0% a year over three years.
- Debt is 0.45× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Biocon — Price
Interval
Style
Failed: 503
Scorecard
Market: risk-off · breadth 372/8Minerviniuptrend checks met
31RS Rankvs all stocks, 1–99
bearRSI Regimemomentum range
41 ▲Trend (ADX)trend strength
0/4CAN SLIMprice & volume checks
downSupertrendprice vs trailing line
downVolume Flowbuying vs selling volume
Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 78.2P/E: 78.2 | P/B: 1.77Growth
GrowingSales CAGR — 3Y: 15% · 1Y: 10%Profitability
Low MarginROCE: 3.61% | ROE: 1.4%Key Metrics
Valuation
Price / Sales 3.28x
Price / FCF 693.2x
Book Value ₹210
Margins & returns
Operating Margin 20%
Net Margin 2.4%
Return on Assets 0.7%